![Paul Cossum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Cossum
Directeur/Bestuurslid bij Pivotal BioSciences, Inc.
Oorsprong van het eerstegraads netwerk van Paul Cossum
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 6 | |
Pivotal BioSciences, Inc.
![]() Pivotal BioSciences, Inc. BiotechnologyHealth Technology Pivotal BioSciences, Inc. operates as an early-stage company which engages in the development and commercialization of cancer therapies. Its product pipeline includes PB 101, PB 103 and PB 105. The company was founded by Alan Epstein, Francis S. Markland, Jr. and Dimitri S. Villard in 1998 and is headquartered in Los Angeles, CA.
3
| Private Company | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Paul Cossum via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nodality, Inc.
![]() Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BLACKSTONE INC. | Investment Managers | Corporate Officer/Principal | |
OXFORD IMMUNOTEC GLOBAL PLC | Medical Specialties | Director/Board Member | |
Clarus Lifesciences III LP
![]() Clarus Lifesciences III LP Investment ManagersFinance Clarus Lifesciences III LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of pharmaceutical, biotechnology and medical devices. It provides financing for seed, early and later stage capital requirements with an investment size of USD 15 - 50 million. | Investment Managers | Corporate Officer/Principal | |
Variation Biotechnologies (US), Inc.
![]() Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Verband Beratender Ingenieure VBI
![]() Verband Beratender Ingenieure VBI Miscellaneous Commercial ServicesCommercial Services Verband Beratender Ingenieure VBI is a consulting and engineering association based in Germany. | Miscellaneous Commercial Services | Director/Board Member | |
ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
VBI VACCINES INC. | Biotechnology | Director/Board Member | |
Quest Diagnostics TB LLC
![]() Quest Diagnostics TB LLC Medical SpecialtiesHealth Technology Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA. | Medical Specialties | Corporate Officer/Principal | |
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Equipment/Instruments | Director/Board Member | |
University of Toronto | College/University | Graduate Degree | |
McGill University | College/University | Undergraduate Degree | |
Davis Polk & Wardwell LLP
![]() Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TransForm Pharmaceuticals, Inc.
![]() TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Clarus Ventures LLC
![]() Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Phoenix Strategy Investments LLC
![]() Phoenix Strategy Investments LLC Investment ManagersFinance Phoenix Strategy Investments LLC (Phoenix Strategy) is a private equity firm founded by Michael R. Zani and Daniel Muzquiz in 2002. The firm is headquartered in Dallas. | Investment Managers | Consultant / Advisor | |
Verity Pharmaceuticals, Inc.
![]() Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
US Food & Drug Administration
![]() US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Chairman | |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Bonn | College/University | Corporate Officer/Principal | |
Hochschule München | College/University | Undergraduate Degree | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of Michigan | College/University | Graduate Degree | |
Kellogg School of Management | College/University | Masters Business Admin | |
XENOPORT, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Angiocrine Bioscience, Inc.
![]() Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Miscellaneous Commercial Services | Director/Board Member | |
Pierian Biosciences LLC
![]() Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Medical/Nursing Services | Director/Board Member | |
International Society for Biological Therapy of Cancer
![]() International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services The International Society for Biological Therapy of Cancer operates as a professional society of influential scientists, academicians, researchers, clinicians, and government representatives. The non-profit company is based in Milwaukee, WI. | Miscellaneous Commercial Services | President | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Refuge Biotechnologies, Inc.
![]() Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Founder | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
XORTX Pharma Corp.
![]() XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member | |
New Enterprise Associates (India) LLC | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 39 |
Canada | 5 |
Duitsland | 4 |
Verenigd Koninkrijk | 3 |
Luxemburg | 2 |
Sectoraal
Health Technology | 26 |
Consumer Services | 9 |
Finance | 7 |
Commercial Services | 6 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 77 |
Corporate Officer/Principal | 29 |
Independent Dir/Board Member | 25 |
Chief Executive Officer | 10 |
President | 8 |
Sterkste connecties
Insiders | |
---|---|
Franklin Berger | 41 |
David Parkinson | 31 |
Scott Requadt | 23 |
Robert W. Rieder | 16 |
Dimitri Villard | 13 |
Peter Virsik | 6 |
Frank Perabo | 4 |
Tom Silberg | 1 |
Stephen Flaim | 1 |
- Beurs
- Insiders
- Paul Cossum
- Bedrijfsconnecties